Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer
- PMID: 27893335
- DOI: 10.1200/JCO.2016.69.2582
Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer
Comment in
-
Reply to M. Lambertini et al.J Clin Oncol. 2017 Mar;35(7):807-809. doi: 10.1200/JCO.2016.70.6101. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893322 No abstract available.
-
Reply to M. Lambertini et al.J Clin Oncol. 2017 Mar;35(7):805-806. doi: 10.1200/JCO.2016.70.6093. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893330 No abstract available.
Comment on
-
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.J Clin Oncol. 2016 Aug 1;34(22):2568-74. doi: 10.1200/JCO.2015.65.8864. Epub 2016 May 23. J Clin Oncol. 2016. PMID: 27217453 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
